Time to first treatment is an independent prognostic factor for Multiple Myeloma (MM)
H Hatic, S Inselman, J Inselman, A Kommalapati… - Leukemia Research, 2022 - Elsevier
Introduction Multiple myeloma (MM) is an incurable plasma cell neoplasm. In this study, we
aimed to analyze the impact of time to initiation of systemic therapy for MM on overall …
aimed to analyze the impact of time to initiation of systemic therapy for MM on overall …